Table 3.
Details of case reports of patients treated with radioactive iodine (131I) as adjuvant (postoperative) treatment
| Reference | Nodal Staging (N) | Iodine Activity Iodine Administered (GBq) | Sites of Iodine Uptake | Uptake on Subsequent Iodine Scans | Calcitonin before Iodine (pg/ml) | Calcitonin after Iodine (pg/ml) |
|---|---|---|---|---|---|---|
| 29 | 1 | 5.5 | thyroid bed | none 1 year later | 890 | 786 |
| 30 | 0 | 1.1 | thyroglossal remnant | reduced a | ||
| 31 | 0 | 5.5 | thyroid bed | 680 | 50 | |
| 28 | 1 | ns | “no distant” | 162 | 40.5 | |
| 32 | ns | 2.7 | thyroid bed | |||
| 32 | ns | 3.4 | thyroid bed | |||
| 32 | 1 | 4.1 | thyroid bed & superior mediastinum | |||
| 32 | 1 | 3.5 | thyroid bed | |||
| 33 b | 1 | 3.0, 5.5 | ns | “none on later scan” | ||
| 33 | ns | ns | neck |
ns, not stated.
calcitonin response to calcium infusion and pentagastrin stimulation both significantly reduced (actual value not given).
also received 131I as treatment for neck recurrence (Table 4).